Skip to main content

stock

HROW · HARROW, INC.

What HARROW, INC. reports to the SEC, read from its filings.

Open in the app

Price

The live HROW price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on HROW.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
37,487,850 as of 2026-08-06 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
73.3%
Operating
-1.0%
Net
-13.5%

Returns

ROE
-244.9%
ROA
-8.9%

Health

Current ratio
2.2x
Debt/equity
—

Deep value

NCAV
-$172.66M
NCAV per share
-$4.61
Price/NCAV
Locked
NNWC
-$220.71M
NNWC per share
-$5.89
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$70.66M$50.36M-$11.01M-$17.27M
10-Q filed 2026-08-10
2026-03-31$44.20M$27.05M-$22.08M-$27.60M
10-Q filed 2026-05-11
2025-12-31$89.09M$70.62M$15.59M$6.63M
DEF 14A filed 2026-04-24
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$71.64M$53.93M$14.75M$1.02M
10-Q filed 2025-11-10
2025-06-30$63.74M$47.51M$11.41M$5.00M
10-Q filed 2026-08-10
2025-03-31$47.83M$32.31M-$11.23M-$17.78M
10-Q filed 2026-05-11
2024-12-31$66.83M$52.70M$12.90M$6.78M
DEF 14A filed 2026-04-24
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$49.26M$37.24M$1.32M-$4.22M
10-Q filed 2025-11-10
Assets
$416.82M
Equity
$15.20M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$272.30M$30.52M-$5.14M$42.98M
2024-12-31$199.61M$8.82M-$17.48M-$23.80M
2023-12-31$130.19M$431,000-$24.41M$2.38M
2022-12-31$88.59M$1.92M-$14.09M-$892,000
2021-12-31$72.48M$1.61M-$18.01M$3.30M
2020-12-31$48.87M$385,000-$3.36M-$1.96M
2019-12-31$51.16M-$4.79M$168,000-$518,000
2018-12-31$41.37M-$5.22M$14.63M-$1.08M
2017-12-31$26.77M-$12.16M-$11.98M-$9.57M
2016-12-31$19.94M-$15.88M-$19.09M-$18.10M

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

  • Shojaei Amir

    CHIEF SCIENTIFIC OFFICER

    Sale$450,000

    Aug 17, 5:47 PM ET

All insider trades for HROW

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named HROW, and the market events around them.

Sign in to see this

Board

The HROW board could not be loaded.

Retry the HROW board

nakagai

Signals on HROW come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the HROW board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

HARROW, INC. (HROW): SEC filings, financials and insider trades · Nakagai